54.56 
0.46(0.84%) 4:02PM EDT
| Prev Close: | 55.02 |
|---|
| Open: | 54.51 |
|---|
| Bid: | 52.20 x 200 |
|---|
| Ask: | 54.89 x 200 |
|---|
| 1y Target Est: | 69.41 |
|---|
| Beta: | 1 |
|---|
| Next Earnings Date: | N/A |
|---|
| Day's Range: | 54.30 - 54.69 |
|---|
| 52wk Range: | 35.50 - 55.94 |
|---|
| Volume: | 581,132 |
|---|
| Avg Vol (3m): | 2,225,060 |
|---|
| Market Cap: | 144.41B |
|---|
| P/E (ttm): | 26.89 |
|---|
| EPS (ttm): | 2.03 |
|---|
| Div & Yield: | 1.30 (2.40%) |
|---|
The broker you select will become the default broker for Trade Now
Quotes delayed, except where indicated otherwise. Currency in USD.
Headlines
- What Do These Factors Suggest About Elan Stock?at Wall St. Cheat Sheet(Tue 2:05PM EDT)
- CryoPort's Game-Changer In Frozen Biological Shippingat Seeking Alpha(Tue 12:54PM EDT)
- Good News for InterMuneZacks(Mon, Jun 17)
- 5 Health Care Stocks Pushing The Sector Higherat TheStreet(Mon, Jun 17)
- Canadians Look to Their Employers to Help Navigate the Public-Private Healthcare MazeCNW Group(Mon, Jun 17)
- Leading Experts in Parenting, Education and Medicine Partner to Launch Head Lice Awareness InitiativePR Newswire(Mon, Jun 17)
- White Collar Criminals Love Biotech Stocksat Motley Fool(Sun, Jun 16)
- 1 Thing You Always Wanted to Know About Drugs (but Were Afraid to Ask)at Motley Fool(Sat, Jun 15)
- The 3 Countries Stealing China's Businessat Motley Fool(Sat, Jun 15)
- A Must Have Pharma Stockat Motley Fool(Fri, Jun 14)
- Sanofi Stock Buy Recommendation Reiterated (SNY)at TheStreet(Fri, Jun 14)
- Near A 52-Week Low, Is OncoGenex Pharmaceuticals A Buy?at Seeking Alpha(Thu, Jun 13)
- KaloBios: An Undervalued Pharmaceutical Company With Remarkable Pipelineat Seeking Alpha(Thu, Jun 13)
- Sanofi's Fluzone Quadrivalent Gets FDA NodZacks(Thu, Jun 13)
- Novartis: 5-Year Revenue Outlookat Seeking Alpha(Thu, Jun 13)
Key Statistics
| Forward P/E (1 yr): | 12.72 |
|---|
| P/S (ttm): | 3.20 |
|---|
| Ex-Dividend Date: | 06-May-13 |
|---|
Analysts
| Annual EPS Est
(Dec-13)
: | 3.76 |
|---|
| Quarterly EPS Est
(Mar-13)
: | N/A |
|---|
| Mean Recommendation*: | 1.8 |
|---|
| PEG Ratio (5 yr expected): | 2.05 |
|---|
Business Summary
Sanofi researches, develops, manufactures, and markets healthcare products worldwide. The company operates through Pharmaceuticals, Human Vaccines, and Animal Health segments.
View More